معرفی
Aryelly Rodriguez is a Research Fellow at the Usher Institute within the College of Medicine and Veterinary Medicine at the University of Edinburgh, based at the Edinburgh Clinical Trials Unit. Her expertise centers on medical informatics, clinical trial data management, and privacy-preserving methodologies for health data sharing.
Her academic qualifications include:
- PhD in Medical Informatics, University of Edinburgh (2017-2024)
- MSc in Applied Statistics, Sheffield Hallam University (2006)
- MSc in Business Administration and Management, University of Aberdeen (2000)
- BSc in Production Engineering, Universidad Simón Bolívar (1998)
Dr. Rodriguez's research focuses on critical challenges in clinical data privacy, particularly re-identification risks in anonymized trial datasets and ethical data sharing frameworks. She investigates statistical disclosure control methods while advancing digital health endpoints through wearable technologies and patient-centered outcome measures. Her work bridges biostatistics, regulatory science, and real-world clinical applications to enhance trial validity and participant safety.
Analysis of her recent publications reveals converging themes: robust anonymization protocols for clinical datasets, researcher perspectives on data de-identification practices, and innovative trial designs like the Macrophage Therapy for Acute Liver Injury (MAIL) study. Her output demonstrates growing emphasis on practical implementation of privacy frameworks alongside emerging digital endpoint methodologies.
No major scientific awards are documented in available sources.
Dr. Rodriguez accepts PhD students and serves as a Statistical Expert on the Medical Research Council's Developmental Pathway Funding Scheme Panel. Her grant involvement spans clinical trials including the MAIL study for paracetamol-induced liver injury, reflecting active collaboration with hepatology and regenerative medicine teams.
She operates within the Edinburgh Clinical Trials Unit at the Usher Building, collaborating closely with the Centre for Population Health Sciences on cluster randomized trials, trauma research, and stillbirth awareness initiatives. Her network extends to multi-stakeholder digital health consortia focused on wearable integration and endpoint validation.
